NASDAQ:TNXP - US8902608392 - Common Stock
Overall TNXP gets a fundamental rating of 4 out of 10. We evaluated TNXP against 549 industry peers in the Biotechnology industry. TNXP has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, TNXP is valued expensive at the moment.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -43.46% | ||
ROE | -48.47% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 29.27% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | 3.35 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 7.53 | ||
Quick Ratio | 7.22 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
37.98
+2.13 (+5.94%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 33.88 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.98 | ||
P/tB | 1.98 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -43.46% | ||
ROE | -48.47% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 29.27% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 27.5% | ||
Cap/Sales | 5.54% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 7.53 | ||
Quick Ratio | 7.22 | ||
Altman-Z | 3.35 |